Literature DB >> 16972785

Evidence supporting the hypothesis that one of the main functions of the aryl hydrocarbon receptor is mediation of cell stress responses.

Fumio Matsumura1, Christoph F A Vogel.   

Abstract

We have previously proposed that one of the major consequences of activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) could be elicitation of 'cell stress response' reactions [Matsumura, Biochem. Pharmacol. 66 (2003), 527-540]. This hypothesis was based mainly on the similarity between the toxic symptoms, particularly those related to the wasting syndrome, and those induced by bacterial endotoxins, namely lipopolysaccharides (LPS) in vivo, as well as the biochemical and molecular consequences of their toxic actions in vitro. Since the basic action mechanism of LPS as an inducer of cell stress responses (CSR) is known to some extent, including knowledge of their specific receptors (i.e., toll-like receptors) and their signaling process through the inflammatory response messengers, the above comparison offered a good point of reference to this subject. Furthermore, the process of constructing this hypothesis itself has provided us with a good opportunity to give a fresh view on the toxic action patterns of TCDD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972785     DOI: 10.1515/BC.2006.146

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  13 in total

1.  How T cells take developmental decisions by using the aryl hydrocarbon receptor to sense the environment.

Authors:  Thomas Korn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-17       Impact factor: 11.205

2.  The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.

Authors:  Kanae Bekki; Helena Vogel; Wen Li; Tomohiro Ito; Colleen Sweeney; Thomas Haarmann-Stemmann; Fumio Matsumura; Christoph F A Vogel
Journal:  Pestic Biochem Physiol       Date:  2014-12-23       Impact factor: 3.963

Review 3.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

4.  Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

Authors:  Christoph F A Vogel; Wen Li; Eric Sciullo; John Newman; Bruce Hammock; J Rachel Reader; Joseph Tuscano; Fumio Matsumura
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

5.  RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.

Authors:  Christoph F A Vogel; Eric Sciullo; Wen Li; Pat Wong; Gwendal Lazennec; Fumio Matsumura
Journal:  Mol Endocrinol       Date:  2007-09-06

6.  Characterization of the pattern of the nongenomic signaling pathway through which TCDD-induces early inflammatory responses in U937 human macrophages.

Authors:  Eric M Sciullo; Bin Dong; Chris F A Vogel; Fumio Matsumura
Journal:  Chemosphere       Date:  2009-01-21       Impact factor: 7.086

7.  Regulation of mouse small heat shock protein αb-crystallin gene by aryl hydrocarbon receptor.

Authors:  Shuang Liu; Joram Piatigorsky
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

Review 8.  Association of dioxin and other persistent organic pollutants (POPs) with diabetes: epidemiological evidence and new mechanisms of beta cell dysfunction.

Authors:  Vincenzo De Tata
Journal:  Int J Mol Sci       Date:  2014-05-05       Impact factor: 5.923

Review 9.  AhR-Mediated, Non-Genomic Modulation of IDO1 Function.

Authors:  Maria Teresa Pallotta; Francesca Fallarino; Davide Matino; Antonio Macchiarulo; Ciriana Orabona
Journal:  Front Immunol       Date:  2014-10-15       Impact factor: 7.561

10.  The role of oxidative stress in carcinogenesis induced by metals and xenobiotics.

Authors:  Frank Henkler; Joep Brinkmann; Andreas Luch
Journal:  Cancers (Basel)       Date:  2010-04-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.